Laribi, Kamel
Badinand, Delphine
Janoray, Philippe
Benabed, Khaled
Mouysset, Jean-Loup
Fabre, Elizabeth
Monchecourt, Françoise
Diab, Rafik
Funding for this research was provided by:
Teva Pharmaceutical Industries
Article History
Received: 19 September 2018
Accepted: 1 March 2019
First Online: 14 March 2019
Compliance with ethical standards
: Oral consent was obtained from each patient included. The study was conducted according to the ethical principles of the Declaration of Helsinki and in accordance with Good Epidemiological Practices. Approvals from the French review boards (Advisory Committee for data processing in Health Research [CCTIRS] and French data protection authority [CNIL]) were obtained.
: K.L. has received grants and personal fees from Novartis and Takeda; grants from Roche, Mundipharma, Hospira, and Teva Santé; and personal fees from Amgen. F.M. is an employee of Teva Santé. All remaining authors have declared no conflicts of interest.